Aligos Therapeutics, Inc.

ALGS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$36,997$135,704$81,347$186,816
Short-Term Investments$19,942$0$44,480$3,918
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$5,202$5,380$7,718$13,690
Total Curr. Assets$62,141$141,084$133,545$204,424
Property Plant & Equip (Net)$7,326$9,818$12,514$14,969
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$15,110
Tax Assets$0$0$0$0
Other NC Assets$627$625$634$866
Total NC Assets$7,953$10,443$13,148$30,945
Other Assets$0$0$0$0
Total Assets$70,094$151,527$146,693$235,369
Liabilities
Payables$2,571$2,517$4,737$3,015
Short-Term Debt$3,458$3,239$3,143$2,907
Tax Payable$0$0$0$0
Deferred Revenue$151$1,308$9,210$7,641
Other Curr. Liab.$15,557$16,842$16,039$25,394
Total Curr. Liab.$21,737$23,906$33,129$38,957
LT Debt$4,917$7,899$9,431$11,548
Deferred Rev, NC$0$0$233$0
Deferred Tax Liab, NC$1,757$0$0$0
Other NC Liab.$72,413$27,642$0$133
Total NC Liab.$79,087$35,541$9,664$11,681
Other Liabilities-$1,757$0$0$0
Cap. Leases$8,375$11,138$12,574$14,455
Total Liabilities$99,067$59,447$42,793$50,638
Equity
Pref Stock$0$0$0$0
Common Stock$8$7$4$4
Retained Earnings-$618,008-$486,797-$399,118-$303,072
AOCI$451$545$401$452
Other Equity$588,576$578,325$502,613$487,347
Total Equity-$28,973$92,080$103,900$184,731
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$70,094$151,527$146,693$235,369
Net Debt-$28,622-$124,566-$68,773-$172,361